FY2026 Q2 Earnings Presentation

Overview of Performance

Asahi Kasei reported first-half FY2026 net sales of 1,689.6 hundred million yen (+13.7% YoY), operating income of 165.4 hundred million yen (+54.0% YoY), and interim net income attributable to owners of parent of 102.2 hundred million yen, representing substantial profit growth. Profit growth was driven by focus growth areas (Pharmaceuticals & Life Sciences, Critical Care, Electronics). The full-year forecast was revised upward, with operating income projected at 290.0 hundred million yen. Multiple factors, including inventory effects in Materials and yen depreciation, are expected to underpin profit improvement. The company executed cancellation of acquired treasury shares and presented a shareholder return policy targeting DOE of 3.1%.

Outlook and Capital Policy

The full-year forecast has been revised upward, aiming for the third consecutive fiscal year of record-high profits. In addition to expanding focus growth areas, the company will accelerate price pass-through and cost reductions in Materials. From FY2026 onward, the capital policy will strengthen shareholder returns and continue reducing held shares. Treasury stock acquisition has been completed and the acquired shares have been cancelled. Dividends are expected to be 48 yen annually (24 yen interim), with DOE around 3.1%.